Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-04-09 15:16 Tx date 2021-04-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,878.36
-2,604 vol $11.09 each |
0 | |
Filed 2021-04-09 15:15 Tx date 2021-04-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$11,014
+2,604 vol $4.23 each |
2,604 | |
Filed 2021-04-09 15:13 Tx date 2021-04-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-11,014.92
-2,604 vol $4.23 each |
68,929 | |
Filed 2021-04-09 15:11 Tx date 2021-04-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,031.72
-2,708 vol $11.09 each |
0 | |
Filed 2021-04-09 15:10 Tx date 2021-04-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,029
+2,708 vol $0.38 each |
2,708 | |
Filed 2021-04-09 15:08 Tx date 2021-04-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,029.04
-2,708 vol $0.38 each |
71,533 | |
Filed 2021-03-12 15:43 Tx date 2021-03-10 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,852.32
-2,604 vol $11.08 each |
0 | |
Filed 2021-03-12 15:42 Tx date 2021-03-10 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$11,014
+2,604 vol $4.23 each |
2,604 | |
Filed 2021-03-12 15:37 Tx date 2021-03-10 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-11,014.92
-2,604 vol $4.23 each |
74,241 | |
Filed 2021-03-12 15:34 Tx date 2021-03-10 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,004.64
-2,708 vol $11.08 each |
0 | |
Filed 2021-03-12 15:33 Tx date 2021-03-10 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,029
+2,708 vol $0.38 each |
2,708 | |
Filed 2021-03-12 15:29 Tx date 2021-03-10 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,029.04
-2,708 vol $0.38 each |
76,845 | |
Filed 2021-02-10 20:27 Tx date 2021-02-09 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,200.392
-508 vol $14.17 each |
0 | |
Filed 2021-02-10 20:25 Tx date 2021-02-09 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$6,207
+508 vol $12.22 each |
508 | |
Filed 2021-02-10 20:24 Tx date 2021-02-09 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-6,207.76
-508 vol $12.22 each |
79,553 | |
Filed 2021-02-10 20:14 Tx date 2021-02-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,940.60
-2,604 vol $12.65 each |
0 | |
Filed 2021-02-10 20:13 Tx date 2021-02-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$11,014
+2,604 vol $4.23 each |
2,604 | |
Filed 2021-02-10 20:12 Tx date 2021-02-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-11,014.92
-2,604 vol $4.23 each |
80,061 | |
Filed 2021-02-10 20:07 Tx date 2021-02-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-34,256.20
-2,708 vol $12.65 each |
0 | |
Filed 2021-02-10 20:05 Tx date 2021-02-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,029
+2,708 vol $0.38 each |
2,708 | |
Filed 2021-02-10 20:00 Tx date 2021-02-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,029.04
-2,708 vol $0.38 each |
82,665 | |
Filed 2021-01-12 19:29 Tx date 2021-01-11 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,725.3084
-508 vol $15.21 each |
0 | |
Filed 2021-01-12 19:28 Tx date 2021-01-11 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$6,207
+508 vol $12.22 each |
508 | |
Filed 2021-01-12 19:26 Tx date 2021-01-11 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-6,207.76
-508 vol $12.22 each |
85,373 | |
Filed 2021-01-12 19:25 Tx date 2021-01-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,364.604
-2,604 vol $15.50 each |
0 | |
Filed 2021-01-12 19:22 Tx date 2021-01-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$11,014
+2,604 vol $4.23 each |
2,604 | |
Filed 2021-01-12 19:21 Tx date 2021-01-08 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-11,014.92
-2,604 vol $4.23 each |
85,881 | |
Filed 2021-01-12 16:41 Tx date 2021-01-07 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-39,842.804
-2,708 vol $14.71 each |
0 | |
Filed 2021-01-12 16:38 Tx date 2021-01-07 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,029
+2,708 vol $0.38 each |
2,708 | |
Filed 2021-01-12 16:35 Tx date 2021-01-07 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-1,029.04
-2,708 vol $0.38 each |
88,485 | |
Filed 2021-01-04 13:39 Tx date 2020-12-31 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-562,638.384
-38,808 vol $14.50 each |
0 | |
Filed 2021-01-04 13:38 Tx date 2020-12-31 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$542,535
+38,808 vol $13.98 each |
38,808 | |
Filed 2021-01-04 13:37 Tx date 2020-12-31 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-272,562.40
-18,800 vol $14.50 each |
0 | |
Filed 2021-01-04 13:37 Tx date 2020-12-31 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$229,736
+18,800 vol $12.22 each |
18,800 | |
Filed 2021-01-04 13:35 Tx date 2020-12-31 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-542,535.84
-38,808 vol $13.98 each |
91,193 | |
Filed 2021-01-04 13:34 Tx date 2020-12-31 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-229,736
-18,800 vol $12.22 each |
130,001 | |
Filed 2020-12-28 16:37 Tx date 2020-12-23 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+140,000 vol |
247,895 | |
Filed 2020-12-18 20:51 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,361.65
-4,250 vol $11.85 each |
0 | |
Filed 2020-12-18 20:49 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$31,875
+4,250 vol $7.50 each |
4,250 | |
Filed 2020-12-18 20:48 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-239,674.0548
-20,226 vol $11.85 each |
0 | |
Filed 2020-12-18 20:47 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$168,684
+20,226 vol $8.34 each |
20,226 | |
Filed 2020-12-18 20:46 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-164,131.5798
-13,851 vol $11.85 each |
0 | |
Filed 2020-12-18 20:43 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$127,429
+13,851 vol $9.20 each |
13,851 | |
Filed 2020-12-18 20:42 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-309,149.4322
-26,089 vol $11.85 each |
0 | |
Filed 2020-12-18 20:40 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$270,021
+26,089 vol $10.35 each |
26,089 | |
Filed 2020-12-18 20:39 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-199,977.2248
-16,876 vol $11.85 each |
0 | |
Filed 2020-12-18 20:38 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$71,385
+16,876 vol $4.23 each |
16,876 | |
Filed 2020-12-18 20:36 Tx date 2020-12-16 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-556,020.612
-48,228 vol $11.53 each |
0 | |
Filed 2020-12-18 20:36 Tx date 2020-12-16 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$204,004
+48,228 vol $4.23 each |
48,228 | |
Filed 2020-12-18 20:33 Tx date 2020-12-16 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-163,377.459
-14,171 vol $11.53 each |
0 | |
Filed 2020-12-18 20:31 Tx date 2020-12-16 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$5,384
+14,171 vol $0.38 each |
14,171 | |
Filed 2020-12-18 20:29 Tx date 2020-12-15 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-244,660.31
-21,037 vol $11.63 each |
0 | |
Filed 2020-12-18 20:28 Tx date 2020-12-15 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$7,994
+21,037 vol $0.38 each |
21,037 | |
Filed 2020-12-18 20:27 Tx date 2020-12-15 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-501,159.96
-43,092 vol $11.63 each |
0 | |
Filed 2020-12-18 20:26 Tx date 2020-12-15 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$33,180
+43,092 vol $0.77 each |
43,092 | |
Filed 2020-12-18 20:24 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-31,875
-4,250 vol $7.50 each |
148,801 | |
Filed 2020-12-18 20:16 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-168,684.84
-20,226 vol $8.34 each |
153,051 | |
Filed 2020-12-18 20:16 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-127,429.20
-13,851 vol $9.20 each |
173,277 | |
Filed 2020-12-18 20:14 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-270,021.15
-26,089 vol $10.35 each |
187,128 | |
Filed 2020-12-18 20:13 Tx date 2020-12-17 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-71,385.48
-16,876 vol $4.23 each |
213,217 | |
Filed 2020-12-18 20:12 Tx date 2020-12-16 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-204,004.44
-48,228 vol $4.23 each |
230,093 | |
Filed 2020-12-18 20:11 Tx date 2020-12-16 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-5,384.98
-14,171 vol $0.38 each |
278,321 | |
Filed 2020-12-18 20:10 Tx date 2020-12-15 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-7,994.06
-21,037 vol $0.38 each |
292,492 | |
Filed 2020-12-18 20:09 Tx date 2020-12-15 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
52 - Expiration of options
|
$-33,180.84
-43,092 vol $0.77 each |
313,529 | |
Filed 2020-12-18 19:15 Tx date 2020-12-14 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,255,613.0784
-106,908 vol $11.74 each |
0 | |
Filed 2020-12-18 19:13 Tx date 2020-12-14 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$82,319
+106,908 vol $0.77 each |
106,908 | |
Filed 2020-12-18 19:11 Tx date 2013-04-09 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-12-18 19:10 Tx date 2020-12-14 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
51 - Exercise of options
|
$-82,319.16
-106,908 vol $0.77 each |
356,621 | |
Filed 2020-12-18 17:58 Tx date 2020-09-29 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
90 - Change in the nature of ownership
|
+463,529 vol |
463,529 | |
Filed 2020-12-18 17:57 Tx date 2013-04-09 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-12-18 17:56 Tx date 2020-09-29 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
90 - Change in the nature of ownership
|
-463,529 vol |
107,895 | |
Filed 2020-12-18 17:52 Tx date 2020-09-29 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
-463,529 vol |
||
Filed 2020-12-18 17:52 Tx date 2013-04-09 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-12-18 17:19 Tx date 2013-04-09 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-12-18 17:18 Tx date 2020-09-29 |
$TRIL
Trillium Therapeutics Inc. |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
97 - Other
|
-463,529 vol |
||
Filed 2019-11-12 10:40 Tx date 2019-11-07 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,400
+130,000 vol $0.38 each |
571,424 | |
Filed 2019-05-27 12:21 Tx date 2019-05-10 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+150,000 vol $0.77 each |
441,424 | |
Filed 2018-11-09 Tx date 2018-11-08 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$528,750
+125,000 vol $4.23 each |
291,424 | |
Filed 2017-11-13 Tx date 2017-11-09 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$298,045
+24,390 vol $12.22 each |
166,424 | |
Filed 2016-11-10 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,429
+13,851 vol $9.20 each |
142,034 | |
Filed 2016-05-30 Tx date 2016-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+38,808 vol |
128,183 | |
Filed 2015-11-20 Tx date 2015-11-19 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+38,808 vol |
89,375 | |
Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-606,816 vol |
30,340 | |
Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+26,090 vol |
637,156 | |
Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+20,227 vol |
50,567 | |
Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+4,250 vol |
1,393,777 | |
Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-127,514 vol |
1,389,527 | |
Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Petrova, Penka
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-782,711 vol |
611,066 |